OraSure Technologies' GAAP loss for 3 months of 2022 was $19.967 million, compared to a profit of $3.774 million in the previous year. Revenue increased 15.6% to $67.707 million from $58.582 million a year earlier.

OraSure Technologies' GAAP loss for 2021 was $22.998 million, up 54.1% from $14.922 million in the prior year. Revenue increased 36.1% to $233.674 million from $171.721 million a year earlier.

OraSure Technologies has launched OraQuick in Europe, the world's first oral swab test for HIV-1 and HIV-2. The test is available in 6 European countries: UK, Germany, France, Italy, Spain and Portugal. You can do the test yourself at home. The test results will be available in 20 minutes and is more than 99% accurate.

OraSure Technologies reported a GAAP loss of $12.605 million for 9M 2021, down 24.9% from $16.782 million in the previous year. Revenues increased 56.3% to $170.106 million from $108.866 million a year earlier.